Richard Labaudiniere is the founder of Protego Biopharma. Protego Biopharma has raised $181M in total funding. Latest round: Series B.
Richard Labaudiniere is a co-founder and Chief Executive Officer of Protego Biopharma, a clinical-stage biotechnology company focused on protein misfolding diseases. He holds a PhD and has been instrumental in advancing Protego's lead candidate, PROT-001, through Phase 1 into a pivotal clinical trial.
Full founder directory · Investor directory · Company funding database · Fundraising library